deltorphin i, ala(2)- has been researched along with enkephalin-met, arg(6)-phe(7)- in 1 studies
Studies (deltorphin i, ala(2)-) | Trials (deltorphin i, ala(2)-) | Recent Studies (post-2010) (deltorphin i, ala(2)-) | Studies (enkephalin-met, arg(6)-phe(7)-) | Trials (enkephalin-met, arg(6)-phe(7)-) | Recent Studies (post-2010) (enkephalin-met, arg(6)-phe(7)-) |
---|---|---|---|---|---|
122 | 0 | 4 | 189 | 1 | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barlow, M; Caffrey, JL; Davis, S; Deo, SH; Farias, M; Yoshishige, D | 1 |
1 other study(ies) available for deltorphin i, ala(2)- and enkephalin-met, arg(6)-phe(7)-
Article | Year |
---|---|
The monosialosyl ganglioside GM-1 reduces the vagolytic efficacy of delta2-opioid receptor stimulation.
Topics: Analgesics, Opioid; Animals; Benzylidene Compounds; Bradycardia; Dogs; Dose-Response Relationship, Drug; Enkephalin, Methionine; Female; G(M1) Ganglioside; Male; Naltrexone; Narcotic Antagonists; Oligopeptides; Receptors, Opioid, delta; Sinoatrial Node; Stimulation, Chemical; Vagus Nerve | 2006 |